Cargando…

HSP90 as a novel molecular target in non-small-cell lung cancer

Lung cancer remains the most lethal cancer, with over 160,000 annual deaths in the USA alone. Over the past decade, the discovery of driver mutations has changed the landscape for the treatment of non-small-cell lung cancer (NSCLC). Targeted therapies against epidermal growth factor receptor (EGFR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esfahani, Khashayar, Cohen, Victor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310695/ https://www.ncbi.nlm.nih.gov/pubmed/28210156 http://dx.doi.org/10.2147/LCTT.S60344

Ejemplares similares

A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer
por: Esfahani, Khashayar, et al.
Publicado: (2014)

Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target
por: Gallegos Ruiz, Mariëlle I., et al.
Publicado: (2008)

Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer
por: Restall, Ian J., et al.
Publicado: (2010)

HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
por: Lai, Chien-Hao, et al.
Publicado: (2013)

Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
por: Proia, David A., et al.
Publicado: (2012)

Targeting HSP90 for cancer therapy
por: Mahalingam, D, et al.
Publicado: (2009)

Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer
por: Liu, Kang, et al.
Publicado: (2019)

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells
por: Wang, Yue-qin, et al.
Publicado: (2020)

Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses
por: Vashist, Surender, et al.
Publicado: (2015)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer
por: Xiong, Yuanping, et al.
Publicado: (2019)

Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
por: Hyun, Seung Yeob, et al.
Publicado: (2018)

CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach
por: Bhattacharyya, Nirjhar, et al.
Publicado: (2022)

Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib
por: Wang, Liman, et al.
Publicado: (2019)

Inhibiting the molecular evolution of cancer through HSP90
por: Martins, Ana Sofia, et al.
Publicado: (2012)

Targeting Hsp90 in urothelial carcinoma
por: Chehab, Mahmoud, et al.
Publicado: (2015)

Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation
por: Zhou, Cong, et al.
Publicado: (2023)

Heat Shock Protein 90 (Hsp90) as a Molecular Target for the Development of Novel Drugs Against the Dermatophyte Trichophyton rubrum
por: Jacob, Tiago R., et al.
Publicado: (2015)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
por: Chen, Yaoyu, et al.
Publicado: (2013)

Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
por: Gao, Yanhong, et al.
Publicado: (2013)

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
por: Zhang, Jian, et al.
Publicado: (2022)

A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α
por: Mehta, Adi, et al.
Publicado: (2011)

A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
por: Shahinas, Dea, et al.
Publicado: (2013)

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
por: Qin, Shurong, et al.
Publicado: (2022)

Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
por: Tukaj, Stefan, et al.
Publicado: (2022)

The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90
por: Alberti, Giusi, et al.
Publicado: (2022)

HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer
por: O'Connell, Brenda C., et al.
Publicado: (2014)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017)

Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells
por: Qin, Dong-Jun, et al.
Publicado: (2015)

Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling
por: Siddiqui, Farid Ahmad, et al.
Publicado: (2021)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Review: The HSP90 molecular chaperone—an enigmatic ATPase
por: Pearl, Laurence H.
Publicado: (2016)

Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib
por: Courtin, Aurelie, et al.
Publicado: (2016)

Complex Crystal Structure Determination and in vitro Anti–non–small Cell Lung Cancer Activity of Hsp90(N) Inhibitor SNX-2112
por: Zhao, Dong, et al.
Publicado: (2021)

The Disassociation of the A20/HSP90 Complex via Downregulation of HSP90 Restores the Effect of A20 Enhancing the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents
por: Shen, Li-jun, et al.
Publicado: (2021)

Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer
por: Wang, Lei, et al.
Publicado: (2019)

Diagnostic value of HSP90α and related markers in lung cancer
por: Yuan, Zhimin, et al.
Publicado: (2022)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u47eag4s57g95seastecjo4sc7